40
NPS Score
VS
Aimmune Therapeutics
- EMPLOYEE
PARTICIPANTS - 8
- TOTAL
RATINGS
Biogen Claimed Company
- EMPLOYEE
PARTICIPANTS - 193
- TOTAL
RATINGS
Aimmune Therapeutics vs Biogen
Compare Aimmune Therapeutics versus Biogen for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 8 employees and customers of Aimmune Therapeutics and 193 employees and customers of Biogen.
Aimmune Therapeutics
Aimmune Therapeutics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Aimmune Therapeutics. Their current market cap is $2.26B.
Biogen
Biogen's brand is ranked #388 in the list of Global Top 1000 Brands, as rated by customers of Biogen. Their current market cap is $42.46B.
3.4/5
Product Quality
4/5
2.5/5
Pricing
3.8/5
5/5
Customer Service
3.8/5
| 60% | Promoters |
|---|---|
| 20% | Passive |
| 20% | Detractors |
Net Promoter Score
Winner by 19
21
NPS Score
| 53% | Promoters |
|---|---|
| 15% | Passive |
| 32% | Detractors |
See how Aimmune Therapeutics compares to its competitors
See how Biogen compares to its competitors
Working at Aimmune Therapeutics vs Working at Biogen
85 / 100
CEO Rating
Winner by 19%
66 / 100
CEO Rating
Aimmune Therapeutics
Aimmune Therapeutics doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Biogen
Employees at Biogen rate their CEO, Michel Vounatsos, 66/100. This score is 19% lower than the scores of Aimmune Therapeutics' CEO, Dr. Jayson Dallas. Employees in the HR and Operations departments rate Michel Vounatsos the highest.